Industry Solutions
See how Cytel cut research time by 50%. Clinical milestones, patent filings, and FDA-related triggers — built for selling into biotech.
Biotech is one of the most signal-rich industries in B2B, yet most sales teams are flying blind. Clinical trial milestones, patent filings, FDA actions, and licensing deals generate a constant stream of buying signals — but they are buried in specialized databases, regulatory filings, and scientific publications that generic sales tools never touch.
Selling into biotech companies demands domain expertise that takes years to build. Buyers — Chief Scientific Officers, Heads of Clinical Operations, VP of Regulatory Affairs — expect vendors to understand the implications of a Phase III readout, the significance of a Breakthrough Therapy Designation, or why a PDUFA date creates operational urgency. Reps who lack this context are screened out immediately.
The biotech market also moves at extreme speed. A single clinical trial result can transform a 50-person startup into a billion-dollar organization overnight, or send a promising company into restructuring. Sales teams that cannot track these inflection points in real time miss the narrow windows when biotech companies are most likely to invest in new vendor relationships.
Clinical Trial Milestones
Phase transitions, enrollment completions, data readout announcements, and trial design changes
Patent & IP Activity
New patent filings, patent expirations, IP licensing agreements, and patent litigation outcomes
FDA & Regulatory Actions
IND approvals, Breakthrough Therapy Designations, PDUFA dates, complete response letters, and advisory committee meetings
Financing & Capital Events
Series rounds, IPOs, secondary offerings, and partnership financing that fund operational expansion
Scientific Leadership Changes
New Chief Scientific Officers, VP Clinical Operations, and Head of Regulatory Affairs appointments
Partnership & Licensing Deals
Co-development agreements, licensing partnerships, CDMO contracts, and CRO engagement announcements
Cytel, a global leader in advanced analytics for life sciences, was operating in a data-rich but insight-poor environment. Teams were losing hours toggling across disconnected tools — LinkedIn, job boards, ClinicalTrials.gov, news sites, and public databases — to prepare for account planning and executive meetings. New hires took especially long to ramp in this complex, domain-specific industry.
Salesmotion centralized all account intelligence into a single platform with real-time visibility into executive changes, clinical trial activity, and strategic initiatives. The platform reduced research time by 50%, cut account planning prep by 30%, and accelerated onboarding by functioning as both a research tool and a learning tool for new reps.
“All of the vendors that I've worked with, all of the onboarding that I have had to deal with, I will say, hands down, Salesmotion was the easiest that I have had.”
Lyndsay Thomson
Head of Sales Operations, Cytel
Cytel results
less research time
tool consolidation
faster account planning
Everything your reps need to research accounts, spot buying signals, and craft relevant outreach.
Track clinical trial phase transitions, data readouts, and enrollment milestones across your target biotech accounts. Know when pipeline progress creates urgency for new vendor relationships.
Monitor patent filings, expirations, and licensing activity that signal strategic shifts — from new therapeutic bets to patent cliff preparation that drives operational change.
Get alerts for IND approvals, Breakthrough Therapy Designations, PDUFA dates, and advisory committee meetings. Regulatory milestones are the strongest buying signals in biotech.
Track Series rounds, IPOs, and partnership financing that fund operational expansion. Newly funded biotech companies are actively building vendor relationships and investing in infrastructure.
Get notified when target companies appoint new CSOs, Heads of Clinical Operations, or VP Regulatory Affairs — the domain experts who influence and approve vendor selections.
Generate personalized messaging that references specific clinical milestones, regulatory events, and strategic shifts — helping reps demonstrate the domain expertise biotech buyers demand.
See how Salesmotion stacks up against manual research and generic CRM data for your industry.
| Feature | Manual Research | Generic CRM Data | Salesmotion |
|---|---|---|---|
| Clinical trial intelligence | Manually searching ClinicalTrials.gov and SEC filings per account | No clinical trial data or pipeline tracking | Automated monitoring of trial milestones, phase transitions, and readouts across all accounts |
| Regulatory signal coverage | Checking FDA databases and press releases individually | Basic news mentions without regulatory specificity | Real-time alerts for IND approvals, PDUFA dates, and Breakthrough Therapy Designations |
| Patent and IP tracking | Searching patent databases per company — hours of specialized work | No patent or IP signal coverage | Automated patent filing, expiration, and licensing activity alerts |
| Account research time | 2-3 hours across specialized biotech databases and news sources | Basic company data with no biotech context | 50% less research time with comprehensive biotech account intelligence |
| Domain expertise for new reps | Months of training before reps can research biotech accounts | No industry-specific learning or guidance | New reps craft informed outreach from day one using AI templates and contextual insights |
Common questions about Salesmotion for Biotech
Salesmotion monitors the signals that drive biotech purchasing decisions: clinical trial milestones, FDA regulatory actions, patent activity, financing events, and scientific leadership changes. This gives reps the domain-specific intelligence they need to engage scientifically sophisticated buyers with credibility.
Yes. Salesmotion monitors clinical trial phase transitions, data readouts, IND approvals, PDUFA dates, and Breakthrough Therapy Designations. This feature was developed in partnership with Cytel, a life sciences analytics company, to ensure it meets the needs of teams selling into biotech.
Biotech companies can transform overnight based on a single clinical result or funding event. Salesmotion provides real-time alerts so your team engages during the narrow windows when biotech companies are actively investing in new vendor relationships, rather than learning about events days later.
Yes. Biotech is one of the most knowledge-intensive industries to sell into. Salesmotion provides AI-generated account briefs, suggested messaging, and contextual insights that help new reps produce quality outreach without years of domain training. Cytel found that Salesmotion functioned as a research and learning tool that dramatically accelerated onboarding.
Biotech focuses specifically on selling into biotech companies — startups, mid-cap, and large-cap biotechs developing therapeutics. Life Sciences covers the broader landscape including pharma, CROs, medical devices, and diagnostic companies. Both pages reference the Cytel case study, as Cytel serves the broader life sciences ecosystem.
Have a question we didn't cover? Talk to our team
Book a personalized demo and see how real-time signals and AI research help biotech teams close more deals.
Join the top-performing sales teams using Salesmotion to build more pipeline and close more deals.
Book a demo
